TrueSite TI™, the fourth generation of WuXia™ cell line platform, leverages targeted integration technique to streamline clone screening and guarantees expression stability.The platform has achieved ...

Dr Maja Petkovic commented “The first FDA approved treatments were CAR-T cells directed against the B cell protein CD19. This ...

WuXi Biologics, a global CRDMO, has launched TrueSite TI, a targeted integration (TI)-based CHO cell line platform.

The global food system faces a pressing need for sustainable innovation, driven by environmental and ethical concerns associated with conventional animal ...

For decades, scientists have known that bacteria can exchange genetic material, in a process called horizontal gene transfer.

Joseph Mikhael, MD, and Krina K. Patel, MD, MSc, discuss considerations for CAR T-Cell therapy in multiple myeloma, including age, access, and bridging therapy.

For immune cells, the actin cytoskeleton is more than a structural scaffold. Immune cells can migrate to sites of infection ...

During a live event, Adriana Rossi, MD, discussed easing CAR T-cell therapy access and highlighted cilta-cel's efficacy in earlier-line myeloma.

The Space Intelligence Production Cell at the Springfield-Beckley Air National Guard Base — which held a ceremonial ribbon-cutting Friday — will be on the front line of informing national leaders of ...

Avant Technologies Inc. (OTCQB: AVAI) (“Avant” or the “Company”), today announced a pivotal evolution in its business ...

In small cell lung cancer (SCLC), the protein DLL3 is a promising target in the development of emerging therapies. In particular, DLL3-targeted therapies have been integral in ant ...

BMW has always been a brand comfortable with challenging the status quo. This week in New York, the German automaker ...